As healthcare professionals, it is crucial to have an in-depth understanding of degenerative diseases such as Parkinson's. This article aims to provide a comprehensive overview of Parkinson's Disease, its etiology, pathophysiology, diagnosis, and treatment.
Parkinson's Disease (PD) is a chronic, progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. The etiology is multifactorial, with genetic and environmental factors playing a role. The ensuing dopamine deficiency leads to the cardinal motor symptoms of PD: bradykinesia, rigidity, tremor, and postural instability.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging can aid in diagnosis but is not typically required. The UK Brain Bank criteria are commonly used, which require the presence of bradykinesia and at least one of either rigidity, 4-6Hz resting tremor, or postural instability.
Treatment of PD is symptomatic, aiming to improve quality of life by controlling symptoms. Pharmacological treatment primarily involves dopamine replacement with Levodopa, often combined with a dopa-decarboxylase inhibitor to increase its bioavailability. Other options include dopamine agonists, MAO-B inhibitors, and deep brain stimulation for refractory cases.
Parkinson's Disease is a progressive condition with a variable course. Non-motor symptoms, including cognitive impairment, psychiatric symptoms, and autonomic dysfunction, often become more prominent as the disease progresses. Future research is focused on neuroprotective strategies and disease-modifying therapies.
In conclusion, Parkinson's Disease is a complex, multifaceted condition requiring a comprehensive and multidisciplinary approach. As healthcare professionals, it is our duty to stay abreast of the latest developments in order to provide the best possible care to our patients.
1.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
2.
Prostate cancer therapies: AI-based image analysis detects early organ damage
3.
Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.
4.
OA Tied to Arthritis AE Risk in ICI-Treated Patients
5.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
1.
The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia
2.
Hematopoietic Recovery After Childhood Therapy: Mechanisms, Clinical Implications, and Emerging Strategies
3.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
4.
Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options
5.
Genomic Control of Erythropoietic Stem Cell Renewal
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
4.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation